Hideto Tamura

机构：Dokkyo Medical University · ORCID：0000-0003-1782-4375

发表论文 182 篇 · 总被引 10981 次 · h-index 29

代表论文

ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone (2024 · Blood · 被引 15)
Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia (2023 · Haematologica · 被引 13)
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021) (2024 · International Journal of Hematology · 被引 9)
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan (2023 · Annals of Hematology · 被引 5)
Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study (2024 · International Journal of Hematology · 被引 4)
Talquetamab in Japanese patients with relapsed/refractory multiple myeloma in the MonumenTAL-1 study (2025 · International Journal of Hematology · 被引 3)